Geoffrey M. Parker Insider Trades & Stock Holdings

CHIEF FINANCIAL OFFICER · Allogene Therapeutics, Inc. · Latest filing Oct 21, 2026

Geoffrey M. Parker, CHIEF FINANCIAL OFFICER at Allogene Therapeutics, Inc. has 1 Form 4 trade on file since Oct 21, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($48.70K), net -$48.70K. Latest filing: disposed of 36.34K shares of $ALLO on Oct 21, 2026 at $1.34.

Trades on file

1

Open-market bought

$0

Open-market sold

$48.70K

Net open-market

-$48.70K

Shares held ($ALLO)

1.05M

Latest filing

Oct 21, 2026

Shares held by Geoffrey M. Parker

• $ALLO1.05M sh

Shares owned after the most recent Form 4 for each company.

All insider trades by Geoffrey M. Parker

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 21, 2026	$ALLO	Sell (Open-market sale)	36.34K	$1.34	$48.70K	1.05M	-3.36%				CHIEF FINANCIAL OFFICER	SEC	Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Geoffrey M. Parker traded

• $ALLO

Frequently asked questions

Has Geoffrey M. Parker been buying or selling stock?

Geoffrey M. Parker has 0 open-market purchases and 1 open-market sale on file, net -$48.70K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Geoffrey M. Parker's latest insider trade?

disposed of 36.34K shares of $ALLO on Oct 21, 2026 at $1.34.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.